We investigated whether the MAPK signaling pathway is responsible for the functional differences observed in primary and metastatic cancer cell lines with or without LOH at Kras and found no discernible difference of ERK1/2 phosphorylation in cancer cell lines with or without LOH of Kras by western blot analyses. The gene discussed is MAPK3; the disease is metastatic malignant neoplasm.